Glenmark Stock: Near 200‑Day SMA, Potential Breakout or Buy‑The‑Dip Opportunity
Glenmark’s latest slide sees the pharma stock near its 200‑day SMA, with a breakout above INR 2,223.34 poised to target the 52‑week high. Watch earnings, approvals, and volume for cues.
- GLENMARK PHARMACEUTICALS LTD
- India
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read